Compare BDC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDC | RGEN |
|---|---|---|
| Founded | 1902 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.6B |
| IPO Year | 1994 | 1995 |
| Metric | BDC | RGEN |
|---|---|---|
| Price | $130.16 | $122.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $148.33 | ★ $172.91 |
| AVG Volume (30 Days) | 244.3K | ★ 758.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | 23.13 | ★ 286.96 |
| EPS | ★ 5.91 | 0.86 |
| Revenue | ★ $2,715,194,000.00 | $141,236,000.00 |
| Revenue This Year | $8.91 | $14.30 |
| Revenue Next Year | $4.70 | $14.52 |
| P/E Ratio | ★ $22.05 | $142.76 |
| Revenue Growth | 10.33 | ★ 35.10 |
| 52 Week Low | $90.99 | $109.66 |
| 52 Week High | $159.99 | $175.77 |
| Indicator | BDC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 53.95 |
| Support Level | $124.37 | $121.25 |
| Resistance Level | $131.49 | $130.56 |
| Average True Range (ATR) | 3.85 | 4.59 |
| MACD | 2.44 | 1.72 |
| Stochastic Oscillator | 96.80 | 98.50 |
Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.